StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health CarelonRx Segment — GAAP Operating Gain by Quarter

CarelonRx Segment — GAAP Operating Gain ($M)

QuarterlyAnnual

Elevance Health CarelonRx Segment — GAAP Operating Gain: $616M in Q3 2026, up 10.8% from a year earlier.

Latest, Q3 2026
616
Period ended Sep 30, 2026
Change on a year earlier
+10.8%
556 in Q3 2025
History
22 quarters
Since Q2 2020
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“|| CarelonRx | 616 | 556 | 10.8 | % | 1,780 | 1,694 | 5.1 | %”

Source: 8-K ER (FY2026Q3, 2026-10-21) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCarelonRx Segment — GAAP Operating Gain ($M)Year on yearSource
Q3 2026Sep 30, 2026616+10.8%8-K ER (FY2026Q3, 2026-10-21) ↗
Q2 2026Jun 30, 2026582+8.6%8-K ER (FY2026Q2, 2026-07-15) ↗
Q1 2026Mar 31, 2026582-3.3%8-K ER (FY2026Q1, 2026-04-22) ↗
Q4 2025Dec 31, 2025724+35.8%8-K ER (FY2025Q4, 2026-01-28) ↗
Q3 2025Sep 30, 2025556-10.2%8-K ER (FY2026Q3, 2026-10-21) ↗
Q2 2025Jun 30, 2025536+7.8%8-K ER (FY2026Q2, 2026-07-15) ↗
Q1 2025Mar 31, 2025602+15.1%8-K ER (FY2026Q1, 2026-04-22) ↗
Q4 2024Dec 31, 2024533+8.8%8-K ER (FY2025Q4, 2026-01-28) ↗
Q3 2024Sep 30, 2024619+29.8%8-K ER (FY2025Q3, 2025-10-21) ↗
Q2 2024Jun 30, 2024497+0.2%8-K ER (FY2025Q2, 2025-07-17) ↗
Q1 2024Mar 31, 2024523+2.1%8-K ER (FY2025Q1, 2025-04-22) ↗
Q4 2023Dec 31, 2023490+3.2%8-K ER (FY2024Q4, 2025-01-23) ↗
Q3 2023Sep 30, 2023477–8-K ER (FY2024Q3, 2024-10-17) ↗
Q2 2023Jun 30, 2023496–8-K ER (FY2024Q2, 2024-07-17) ↗
Q1 2023Mar 31, 2023512–10-Q (2024-04-18) ↗
Q4 2022Dec 31, 2022475+11.2%8-K ER (FY2022Q4, 2023-01-25) ↗

Breakdown

What makes up carelonRx Segment — GAAP Operating Gain

Cite this data

StockData. (2026). Elevance Health CarelonRx Segment — GAAP Operating Gain ($M), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-carelonrx

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.